Predictive Parameter of Myocardoprotection in Patients with Chronic Heart Failure as a Consequence of Myocardial Infarction

Authors

  • Nizamov X. Sh. Samarkand regional branch of the Republican Scientific and Practical Specialized Medical Center for Cardiology, Samarkand, Uzbekistan
  • Kushnazarov R. S. Samarkand regional branch of the Republican Scientific and Practical Specialized Medical Center for Cardiology, Samarkand, Uzbekistan
  • Nurullayev O. U. Samarkand regional branch of the Republican Scientific and Practical Specialized Medical Center for Cardiology, Samarkand, Uzbekistan
  • Ruziyeva А. А. Samarkand regional branch of the Republican Scientific and Practical Specialized Medical Center for Cardiology, Samarkand, Uzbekistan

Keywords:

myocardial infarction, coronary heart disease, chronic heart failure, sodium-dependent glucose transporter type 2 inhibitor, fructose 1, 6 diphosphate (FDP)

Abstract

263 patients with coronary heart disease who underwent MI were examined. Of these, men – 157, women – 106. The average age of all studied was 56.2 ± 1.9 years. Each patient underwent the following examinations: anamnesis collection and examination; general clinical and biochemical studies, electrocardiography (ECG). The manifestations of CHF of both groups were evaluated according to the New York classification, obtained from the results of the 6-minute walk test. In patients who have suffered a myocardial infarction with or without a Q wave, the complication of which was CHF; against the background of basic therapy, the use of FDP significantly effectively affected the quality of life.

Downloads

Published

2023-05-11

How to Cite

X. Sh., N. ., R. S., K. ., O. U., N. ., & А. А. R. . (2023). Predictive Parameter of Myocardoprotection in Patients with Chronic Heart Failure as a Consequence of Myocardial Infarction. Scholastic: Journal of Natural and Medical Education, 2(5), 149–151. Retrieved from https://univerpubl.com/index.php/scholastic/article/view/1473